Literature DB >> 6492124

A micromodification of the CH50 test for the classical pathway of complement.

T J Fetterhoff, R C McCarthy.   

Abstract

A micromodification of the CH50 assay of Kabat and Mayer is described in which the total reaction volume has been reduced five-fold. This assay utilizes sheep red blood cells pooled from multiple animals rather than from a single animal to avoid screening procedures of red blood cells from individual sheep. Analysis of natural hemolysin activity in normal serum revealed a correlation with elevated CH50 titers. However, this correlation does not appear to effect the clinical interpretation of the results.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6492124

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN： 0141-2760


  9 in total

1.  Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study.

Authors:  Brandon M Henry; György Sinkovits; Ivan Szergyuk; Maria Helena Santos de Oliveira; Giuseppe Lippi; Justin L Benoit; Emmanuel J Favaloro; Naomi Pode-Shakked; Stefanie W Benoit; David S Cooper; Veronika Müller; Zsolt Iványi; János Gál; Marienn Réti; László Gopcsa; Péter Reményi; Beáta Szathmáry; Botond Lakatos; János Szlávik; Ilona Bobek; Zita Z Prohászka; Zsolt Förhécz; Dorottya Csuka; Lisa Hurler; Erika Kajdácsi; László Cervenak; Blanka Mező; Petra Kiszel; Tamás Masszi; István Vályi-Nagy; Zoltán Prohászka
Journal:  Front Med (Lausanne)       Date:  2022-04-29

2.  Complement activation and C3 binding by serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.

Authors:  N L Schiller; R A Hatch; K A Joiner
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

3.  Characterization of the susceptibility of Pseudomonas aeruginosa to complement-mediated killing: role of antibodies to the rough lipopolysaccharide on serum-sensitive strains.

Authors:  N L Schiller
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

4.  Complement Markers in Blood and Urine: No Diagnostic Value in Late Silent Antibody-Mediated Rejection.

Authors:  Blanka Mező; Andreas Heilos; Georg A Böhmig; Farsad Eskandary; Markus Wahrmann; Gregor Bond; Nicolas Kozakowski; Philip F Halloran; Krisztina Rusai; Zoltán Prohászka
Journal:  Transplant Direct       Date:  2019-06-27

5.  C4 nephritic factor in patients with immune-complex-mediated membranoproliferative glomerulonephritis and C3-glomerulopathy.

Authors:  Nóra Garam; Zoltán Prohászka; Ágnes Szilágyi; Christof Aigner; Alice Schmidt; Martina Gaggl; Gere Sunder-Plassmann; Dóra Bajcsi; Jürgen Brunner; Alexandra Dumfarth; Daniel Cejka; Stefan Flaschberger; Hana Flögelova; Ágnes Haris; Ágnes Hartmann; Andreas Heilos; Thomas Mueller; Krisztina Rusai; Klaus Arbeiter; Johannes Hofer; Dániel Jakab; Mária Sinkó; Erika Szigeti; Csaba Bereczki; Viktor Janko; Kata Kelen; György S Reusz; Attila J Szabó; Nóra Klenk; Krisztina Kóbor; Nika Kojc; Maarten Knechtelsdorfer; Mario Laganovic; Adrian Catalin Lungu; Anamarija Meglic; Rina Rus; Tanja Kersnik-Levart; Ernesta Macioniene; Marius Miglinas; Anna Pawłowska; Tomasz Stompór; Ludmila Podracka; Michael Rudnicki; Gert Mayer; Jana Reiterova; Marijan Saraga; Jakub Zieg; Eva Sládková; Tamás Szabó; Andrei Capitanescu; Simona Stancu; Miroslav Tisljar; Kresimir Galesic; András Tislér; Inga Vainumäe; Martin Windpessl; Tomas Zaoral; Galia Zlatanova; Dorottya Csuka
Journal:  Orphanet J Rare Dis       Date:  2019-11-08       Impact factor: 4.123

6.  Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection.

Authors:  György Sinkovits; Blanka Mező; Marienn Réti; Veronika Müller; Zsolt Iványi; János Gál; László Gopcsa; Péter Reményi; Beáta Szathmáry; Botond Lakatos; János Szlávik; Ilona Bobek; Zita Z Prohászka; Zsolt Förhécz; Dorottya Csuka; Lisa Hurler; Erika Kajdácsi; László Cervenak; Petra Kiszel; Tamás Masszi; István Vályi-Nagy; Zoltán Prohászka
Journal:  Front Immunol       Date:  2021-03-25       Impact factor: 7.561

7.  Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis.

Authors:  Nóra Garam; Zoltán Prohászka; Ágnes Szilágyi; Christof Aigner; Alice Schmidt; Martina Gaggl; Gere Sunder-Plassmann; Dóra Bajcsi; Jürgen Brunner; Alexandra Dumfarth; Daniel Cejka; Stefan Flaschberger; Hana Flögelova; Ágnes Haris; Ágnes Hartmann; Andreas Heilos; Thomas Mueller; Krisztina Rusai; Klaus Arbeiter; Johannes Hofer; Dániel Jakab; Mária Sinkó; Erika Szigeti; Csaba Bereczki; Viktor Janko; Kata Kelen; György S Reusz; Attila J Szabó; Nóra Klenk; Krisztina Kóbor; Nika Kojc; Maarten Knechtelsdorfer; Mario Laganovic; Adrian Catalin Lungu; Anamarija Meglic; Rina Rus; Tanja Kersnik-Levart; Ernesta Macioniene; Marius Miglinas; Anna Pawłowska; Tomasz Stompór; Ludmila Podracka; Michael Rudnicki; Gert Mayer; Romana Rysava; Jana Reiterova; Marijan Saraga; Tomáš Seeman; Jakub Zieg; Eva Sládková; Tamás Szabó; Andrei Capitanescu; Simona Stancu; Miroslav Tisljar; Kresimir Galesic; András Tislér; Inga Vainumäe; Martin Windpessl; Tomas Zaoral; Galia Zlatanova; Dorottya Csuka
Journal:  Clin Kidney J       Date:  2019-06-21

8.  High-activity Classical and Alternative Complement Pathway Genotypes-Association With Donor-specific Antibody-triggered Injury and Renal Allograft Survival.

Authors:  Blanka Mező; Roman Reindl-Schwaighofer; Farsad Eskandary; Andreas Heinzel; Markus Wahrmann; Konstantin Doberer; Andreas Heilos; Gregor Bond; Johannes Kläger; Nicolas Kozakowski; Helmuth Haslacher; Rainer Oberbauer; Ondřej Viklický; Petra Hrubá; Philip F Halloran; Krisztina Rusai; Zoltán Prohászka; Georg A Böhmig
Journal:  Transplant Direct       Date:  2020-02-10

9.  FHR-5 Serum Levels and CFHR5 Genetic Variations in Patients With Immune Complex-Mediated Membranoproliferative Glomerulonephritis and C3-Glomerulopathy.

Authors:  Nóra Garam; Marcell Cserhalmi; Zoltán Prohászka; Ágnes Szilágyi; Nóra Veszeli; Edina Szabó; Barbara Uzonyi; Attila Iliás; Christof Aigner; Alice Schmidt; Martina Gaggl; Gere Sunder-Plassmann; Dóra Bajcsi; Jürgen Brunner; Alexandra Dumfarth; Daniel Cejka; Stefan Flaschberger; Hana Flögelova; Ágnes Haris; Ágnes Hartmann; Andreas Heilos; Thomas Mueller; Krisztina Rusai; Klaus Arbeiter; Johannes Hofer; Dániel Jakab; Mária Sinkó; Erika Szigeti; Csaba Bereczki; Viktor Janko; Kata Kelen; György S Reusz; Attila J Szabó; Nóra Klenk; Krisztina Kóbor; Nika Kojc; Maarten Knechtelsdorfer; Mario Laganovic; Adrian Catalin Lungu; Anamarija Meglic; Rina Rus; Tanja Kersnik Levart; Ernesta Macioniene; Marius Miglinas; Anna Pawłowska; Tomasz Stompór; Ludmila Podracka; Michael Rudnicki; Gert Mayer; Romana Rysava; Jana Reiterova; Marijan Saraga; Tomáš Seeman; Jakub Zieg; Eva Sládková; Natasa Stajic; Tamás Szabó; Andrei Capitanescu; Simona Stancu; Miroslav Tisljar; Kresimir Galesic; András Tislér; Inga Vainumäe; Martin Windpessl; Tomas Zaoral; Galia Zlatanova; Mihály Józsi; Dorottya Csuka
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.